Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells

NCT00006252 is registered in ClinicalTrials.gov with Cancer and Leukemia Group B as lead sponsor.

NCT NCT00006252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells
Lead sponsor
Cancer and Leukemia Group B
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2001
Completion date
October 31, 2011
Enrollment
47 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma